DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Aurobindo Pharma Limited
03 1Chromo Laboratories India Private Limited
04 1Cipla Ltd.
05 1Hetero Drugs Limited
06 1Hetero Labs Limited
07 1Matrix Pharmacorp Private Limited
08 1Olon S.p.A.
09 1Raks Pharma Pvt. Limited
01 1RITONAVIR
02 1RITONAVIR FORM II
03 6Ritonavir
04 1Ritonavir Form II
01 6India
02 1Italy
03 1U.S.A
04 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-896
Start Marketing Date : 2012-09-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-410
Start Marketing Date : 2024-01-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-018
Start Marketing Date : 2021-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7708
Start Marketing Date : 2018-09-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0117
Start Marketing Date : 1996-03-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0066
Start Marketing Date : 1996-03-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0081
Start Marketing Date : 2024-08-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0086
Start Marketing Date : 2018-11-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-035
Start Marketing Date : 2018-06-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
34
PharmaCompass offers a list of Ritonavir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ritonavir manufacturer or Ritonavir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ritonavir manufacturer or Ritonavir supplier.
A 3prs manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3prs, including repackagers and relabelers. The FDA regulates 3prs manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3prs API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 3prs manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A 3prs supplier is an individual or a company that provides 3prs active pharmaceutical ingredient (API) or 3prs finished formulations upon request. The 3prs suppliers may include 3prs API manufacturers, exporters, distributors and traders.
click here to find a list of 3prs suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 3prs as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 3prs API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 3prs as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 3prs and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 3prs NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 3prs suppliers with NDC on PharmaCompass.
We have 7 companies offering 3prs
Get in contact with the supplier of your choice:
